4//SEC Filing
HOGG JOHN RICHARD 4
Accession 0001144204-13-030851
CIK 0001419583other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:23 PM ET
Size
10.2 KB
Accession
0001144204-13-030851
Insider Transaction Report
Form 4
Cellteck Inc.EOPT
HOGG JOHN RICHARD
Director
Transactions
- Conversion
Options to acquire Series B convertible preferred stock
2013-05-20−25,000→ 0 totalExercise: $2.50From: 2012-05-01Exp: 2015-05-01→ Common Stock (25,000 underlying) - Conversion
Options to acquire common stock
2013-05-20+25,000→ 25,000 totalExercise: $2.50From: 2012-05-01Exp: 2015-05-01→ Common Stock (25,000 underlying)
Holdings
- 0
Options to acquire Series B convertible preferred stock
Exercise: $2.50From: 2012-05-01Exp: 2015-05-01→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The options to purchase up to 25,000 shares of Series B convertible preferred stock were originally granted to Mr. Hogg on May 1, 2012 as options to purchase up to 25,000 shares of common stock of Eos Petro, Inc.'s ("Eos") wholly owned subsidiary Eos Global Petro, Inc. ("Eos Global Petro") for Mr. Hogg's services as a non-employee director of Eos Global Petro. Such options were converted into options to purchase up to 25,000 shares of Series B convertible preferred stock of Eos on October 12, 2012 in connection with the merger of Eos Global Petro and Eos. The options vested immediately on the grant date, were set to expire on May 1, 2015, and had an exercise price of $2.50.
- [F2]On May 20, 2013, Eos filed an amendment to its Articles of Incorporation which effectuated an 800-for-1 reverse stock split of all outstanding shares of its common stock. Upon the filing of such amendment to its Articles of Incorporation, a provision governing the automatic conversion of each share of Series B preferred stock into common stock was triggered, and each share of Series B preferred stock automatically converted on a 1:1 ratio into a share of common stock of Eos. Now that the provision governing the automatic conversion of all shares of Series B preferred stock of Eos has been triggered, any outstanding options which previously were to purchase shares of Series B preferred stock, including the options referenced above, have converted into options to purchase an equal number of shares of common stock. The exercise prices, vesting conditions and expiration dates remain unchanged for all such converted options.
Documents
Issuer
Cellteck Inc.
CIK 0001419583
Entity typeother
Related Parties
1- filerCIK 0001560722
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:23 PM ET
- Size
- 10.2 KB